The two compounds exhibited inhibitory effects of biomarkers (5αR2, AR, PSA, and PCNA) related to BPH on testosterone propionate (TP)-activated LNCap and RWPE-1 cells. The gene discussed is AR; the disease is benign prostatic hyperplasia.